Scholars Central

Conference abstractPublished 2017

Formulation and evaluation of Ramipril loaded chitosan nanoparticles for better anti hypertension therapy

Authors: Subharaj Saha, D Nagasamy Venkatesh, Annesha Deb

JSS College of Pharmacy, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ramipril is an ACE inhibitor used extensively as a therapeutic agent in the treatment of hypertension, illustrating poor aqueous solubility leading to low oral bioavailability. This study is focused on optimizing the vital physicochemical property by entrapping the drug into the chitosan nanoparticles. This demonstrates formulation and evaluation of ramipril loaded nanoparticles and comparing its efficiency with pure form of ramipril. The ramipril loaded nanoparticles were framed by ionic gelation of chitosan with tripolyphosphate anions. Nanoparticles of different core: Coat ratio were formulated and evaluated for particle size, zeta potential, drug content, drug loading, entrapment efficiency, in vitro drug release, kinetic studies and in vivo oral bioavailability studies. The prepared nanoparticles were white, free flowing and spherical in shape. The infrared spectra and differential scanning calorimetry, thermographs showed stable character of ramipril and chitosan mixture and revealed the absence of drug-polymer interactions. The chitosan nanoparticles batch F1 have a particle diameter of 291.4 nm and a zeta potential of 8.38 mV, highest drug content of 4.81 mg, drug loading of 48.1%, entrapment efficiency of 18.96%. The in vitro release behavior from all the drug loaded batches were found to follow first order and provided sustained release over period of 24 hours. These results indicates that bioavailability is enhanced significantly by employing nanoparticle formulations of ramipril using chitosan offer a new approach to improve the oral bioavailability of poorly soluble drugs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Subharaj Saha”
  • BylineArticles whose byline prints “D Nagasamy Venkatesh”
  • BylineArticles whose byline prints “Annesha Deb”